SnapshotDx Quiz: May 2020 Study on BIVV009 in Bullous Pemphigoid
bullous pemphigoid autoimmune blistering disease histological examination immunofluorescence examination IgG complement deposition dermal-epidermal junction autoantibodies BP180 BP230 complement system BIVV009 C3c-positive biopsies complement component α-C3c hemolytic activity complement CH50 eosinophil infiltration
Studysummary This study reported that specific inhibition of the classical complement pathway with BIVV009 prevented C3 deposition along the dermal-epidermal junction in bullous pemphigoid, reflecting its potential efficacy.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer